Metabolic tolerance implications safe use arginine salt-aztreonam combination neonatal period similar cohorts low birth weight infants size appropriate gestational age aztreonam-arginine ampicillin gentamicin ampicillin empiric treatment neonatal sepsis regimens glucose mg/kg minute immediate hours cumulative days effects Serum arginine insulin values administration aztreonam mmol arginine kilogram changes gentamicin-treated cohort differences cohort serum concentrations glucose ammonia potassium creatinine bilirubin days antibiotic therapy baseline serum arginine concentration high aztreonam group similar rise fall hours infusion arginine urinary fractional excretion clearance gentamicin group indirect bilirubin concentration aztreonam-treated infants mg/dl mumol/L gentamicin-treated infants mg/dl mumol/L modest differential bilirubin response baseline serum level low-arginine doses study ammonia glucose concentrations Aztreonam-arginine neonates conjunction attention metabolism 